Abstract Mechanical forces are essential to maintain skeletal integrity, and microgravity exposure leads to bone loss. The underlying molecular mechanisms leading to the changes in osteoblasts and osteoclast differentiation and function remain to be fully elucidated. Because of the infrequency of spaceflights and payload constraints, establishing in vitro and in vivo systems that mimic microgravity conditions becomes necessary. We have established a simulated microgravity (modeled microgravity, MMG) system to study the changes induced in osteoclast precursors. We observed that MMG, on its own, was unable to induce osteoclastogenesis of osteoclast precursors; however, 24 h of MMG activates osteoclastogenesis-related signaling molecules ERK, p38, PLCc2, and NFATc1. Receptor activator of NFkB ligand (RANKL) (with or without M-CSF) stimulation for 3-4 days in gravity of cells that had been exposed to MMG for 24 h enhanced the formation of very large tartrateresistant acid phosphatase (TRAP)-positive multinucleated ([30 nuclei) osteoclasts accompanied by an upregulation of the osteoclast marker genes TRAP and cathepsin K. To validate the in vitro system, we studied the hindlimb unloading (HLU) system using BALB/c mice and observed a decrease in BMD of femurs and a loss of 3D microstructure of both cortical and trabecular bone as determined by micro-CT. There was a marked stimulation of osteoclastogenesis as determined by the total number of TRAP-positive multinucleated osteoclasts formed and also an increase in RANKLstimulated osteoclastogenesis from precursors removed from the tibias of mice after 28 days of HLU. In contrast to earlier reported findings, we did not observe any histomorphometric changes in the bone formation parameters. Thus, the foregoing observations indicate that microgravity sensitizes osteoclast precursors for increased differentiation. The in vitro model system described here is potentially a valid system for testing drugs for preventing microgravity-induced bone loss by targeting the molecular events occurring in microgravity-induced enhanced osteoclastogenesis.
Introduction
Microgravity is the condition of weightlessness experienced by astronauts during spaceflights that causes severe physiological alterations in the human body, one of the most prominent of which is bone loss [1] [2] [3] . Prolonged exposure to a microgravity environment leads to bone loss at an alarming rate of approximately 0.5-2% per month in the load-bearing bones [4, 5] , and the abnormalities reported include osteopenia [6] , decreased bone formation, increased bone resorption [7, 8] , and decreased mineralization [9] , which create an increase in fracture risk following return to Earth. In particular, the bone formation parameters, bone alkaline phosphatase, osteocalcin, and type I procollagen propeptide were decreased, whereas the bone resorption markers procollagen C-telopeptide, deoxypyridinolines, and pyridinoline were increased, in astronauts after a 180-day spaceflight [7] . Data collected from crew members aboard the three Skylab missions exhibited a 50% increase in urinary collagen cross-link products [8] .
Skeletal abnormalities caused by microgravity are not exclusive to humans. Laboratory animals including rats [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] , mice [20, 21] , newts [22] , and rhesus monkeys [23] have been used to study microgravity-induced bone loss. Histomorphometric investigations of rats in spaceflight showed an increase in the number of osteoclasts [18, 19] , and osteoclast-mediated mineral resorption was enhanced and bone formation was decreased in periosteal bones of mice [21] .
For reasons of the infrequency of spaceflights, payload constraints, small numbers of subjects and experiments, human and animal data related to bone loss during spaceflight are limited. Therefore, several ground-based models of microgravity have been developed that simulate microgravity conditions. The -68 head-down tilt model with humans has been shown to simulate the effects of the weightless environment of space. Fourteen weeks of headdown tilt led to a decrease in bone formation markers and an increase in urinary calcium and bone resorption markers similar to those observed in spaceflight [24] . Several ground-based studies to model microgravity (MMG) effects on bone were performed using the rat hindlimb unloading (HLU) model, which produces fluid shifts similar to those occurring in space with minimum evidence of stress [25] , as indicated by continued weight gain [26] , no change in serum corticosteroid levels, and normal circadian rhythms [27] . The mouse HLU model was first reported by Simske and coworkers [28] and has been shown to have a reduction in bone mineral density (BMD), primarily affecting trabecular bone in young growing rats [25] and mice, after 2 weeks of unloading [29] .
Although the HLU model has enabled us to study the changes occurring in the skeleton as a whole, we also need to understand the effect of the lack of mechanical strain on isolated cells. Thus, some in vitro ground-based systems model microgravity and permit investigation into the cellular alterations produced in MMG. We and others have used the rotary cell culture system (RCCS) that was developed at the NASA Johnson Space Center to model microgravity [30] . It is a double-walled rotating bioreactor wherein cells in medium rotate in the vessels as a solid body and the cells maintain their relative position, creating minimal shear stress and mechanical damage of cells. Constant rotation of the biosystem as a solid body subjects the cells to a changing angular gravitational vector, thus approximating the highly reduced vector found in the actual space environment [31] .
Ground-based models of microgravity have focused mainly on osteoblastogenesis [32] , and the molecular mechanisms involved in osteoclastogenesis in microgravity have still not been elucidated. In vitro model systems have shown an indirect effect of MMG on osteoclastogenesis. It was shown that gene expression of the receptor activator of NFkB ligand (RANKL) and osteoprotegerin are altered in the mouse stromal cell line, ST2, placed in modeled hypogravity conditions [33] . Similarly, Rucci et al. [34] reported that MMG stimulates osteoclastogenesis indirectly by an increase in RANKL/OPG ratio in osteoblasts.
The aim of the present work was to determine whether MMG exposure per se directly affects the differentiation capacity of osteoclast precursor cells and, if so, what is the underlying molecular mechanism. Also, there have been conflicting reports in terms of the effect of HLU on bone resorption, some reporting that HLU increases bone resorption [35] while others suggest that bone resorption remains unaltered [36, 37] . Thus, we have addressed this issue by analyzing the effect of HLU on osteoclasts and the ex vivo analysis of differentiation of osteoclast precursors from HLU mice.
Using the in vitro RCCS, we have demonstrated that MMG sensitizes osteoclast precursors to differentiation by partial activation of osteoclastogenesis signaling pathways, and using the in vivo HLU system we have validated the effect of microgravity on osteoclastogenesis of osteoclast precursors ex vivo. These results suggest a direct effect of microgravity on osteoclast precursors as one mechanism causing microgravity-induced bone loss.
Materials and methods

In vitro experimental procedures
Cell culture RAW264.7, a murine macrophage cell line, was purchased from the American Type Culture Collection (Manassas, VA, USA). Cells were maintained in Dulbecco's modified Eagle medium (MEM; Gibco) supplemented with 10% v/v fetal bovine serum (Invitrogen) and antibiotics at 378C in a 5% CO 2 incubator. To isolate mouse bone marrow macrophage precursors, bone marrow was flushed from the cavity of long bones and minced in alpha-modified MEM (MEM-alpha) (Sigma). Cells were cultured in low-adhesion plates for 4 days. Supernatant cells were then transferred to fresh plates and cultured in proliferation medium (1:10 macrophage-colony stimulating factor in MEMalpha).
Rotary cell culture system
The RCCS was purchased from Synthecon and is composed of high aspect ratio vessels (HARVs) that rotate at a set rpm. The HARVs are cylindrical growth chambers that contain an inner cylinder with a capacity of 10 ml and an outer cylinder with a gaseous membrane. The rotational motion of the system prevents sedimentation, creating an optimized suspension culture capable of supporting threedimensional cell growth on microcarrier bead scaffolds. The HARVs used in the RCCS have two essential components: solid body rotation and diffusion-mediated oxygenation. Solid body rotation of the vessel, medium, microcarriers, and cells results in minimal shear stress and mechanical damage of cells. Membrane oxygenation allows diffusion of gases to maintain proper growth conditions but prevents turbulence-inducing air spaces/bubbles [31] . These components are necessary to establish an optimized suspension culture system in microgravity conditions.
Modeled microgravity system for osteoclastogenesis We used 2.5 9 10 5 RAW264.7 cells or mouse bone marrow macrophage precursors, which were incubated with 50-mg microcarrier beads (125-212 lm diameter; Solohill Eng., Ann Arbor, MI, USA) at 378C overnight in each well of low-adhesion six-well plates. After overnight incubation, cells attach around the surface of beads (Fig. 1a) . For MMG exposure, beads with cell aggregates in 10 ml fresh complete Dulbecco's MEM (DMEM) were placed in the vessels of the rotating bioreactor located in an incubator. The vessel was rotated at 9 rpm (speed previously determined by using fluorescent beads so that they remain in suspension) for 24 h. Parallel beadattached cells were cultured in gravity (G) in low-adhesion plates and, to have the same density of cells, cells and beads from one well were divided into three wells with a total medium of 10 ml for all the three wells of six-well plates. All cultures were carried out for 24 h, and then cells were separated from the beads. Cells were either used to prepare cell lysates or were cultured on plates with RANKL (10 ng/ml) and/or M-CSF.
TRAP staining
After 24-h incubation in G and MMG, cells were separated from the beads, the cells were counted, and 2.5 9 10 5 cells were seeded in each well of a six-well plate for stimulation with RANKL (and M-CSF for mouse bone marrow macrophages) and subsequent TRAP staining. After 4 days (for RAW 264.7 cells) or 5-6 days (for mouse bone marrow macrophages), cells were fixed with citrate-acetone-formaldehyde for 2 min, and then stained for TRAP using a commercially available staining kit (Sigma). Dark red TRAP-stained cells containing three or more nuclei were counted as osteoclasts. For further quantification, multinucleated TRAP-positive cells with different numbers of nuclei were counted in three different categories: 3-6 nuclei, 6-30 nuclei, and [30 nuclei. 
Apoptosis assay
The percentage of apoptotic cells was measured by using an annexin V-FITC apoptosis kit (Biosource). Cells were detached from the beads by vortexing for 5-10 s after 24 h MMG or G exposure, and Annexin V-FITC was added to the culture medium at a final concentration of 3 lg/ml and subsequently incubated for 3 min at room temperature. Cells were collected with the culture supernatant, pelleted by centrifugation, washed twice with culture medium to remove excess annexin V-FITC, and resuspended in culture medium to a final concentration of 1 9 10 6 cells/ml. Before flow cytometric analysis, propidium iodide was added to a final concentration of 5 lg/ml. A minimum of 10,000 cells per sample were analyzed using flow cytometry. Apoptotic cells were those that were stained for Annexin-V.
Whole cell and nuclear lysate preparation
Whole cell lysates were prepared from cells that were washed with chilled phosphate-buffered saline (PBS) and lysed in RIPA buffer [50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS)] containing protease inhibitors [phenylmethylsulfonyl fluoride, PMSF (5 mM), pepstatin (1 lg/ml), TPCK (70 lg/ml), leupeptin (0.5 lg/ml), spermidine (1 mM), and spermine (1 mM)] and phosphatase inhibitors (Sigma, St. Louis, MO, USA). Nuclear lysates were prepared from cells as follows: cells were washed with chilled PBS and centrifuged at 800g for 5 min at 48C. Nuclear and cytoplasmic lysates were prepared using the NE-PER kit (Pierce) following the manufacturer's instructions. Protein concentration was quantitated using the Pierce BCA protein assay detection system.
Western blotting
Proteins were resolved by 10% sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose membranes. Blots were probed with the primary antibody as indicated for phosphorylated extracellular-related kinase (phospho-ERK), total ERK (ERK), phosphorylated c-Jun N-terminal kinase (phospho-JNK), total JNK (JNK), phosphorylated p-38 (phospho-p-38), total p-38 (p-38) (Cell Signaling Technology), c-fos, and NFATc1 (Santa Cruz Biotechnology). After incubating with the primary antibody overnight at 48C, membranes were washed and incubated with the appropriate horseradish peroxidase-conjugated secondary antibody for 1 h at room temperature. Membranes were then stripped by incubation with the stripping solution (Pierce) for 15-20 min at room temperature and reprobed as already described to detect other antibodies. Actin antibody (Santa Cruz) was used as the loading control. Protein bands were developed by ECL-Advance (Amersham) and visualized in a FujiFilm LAS-3000 imager.
Reverse transcriptase-polymerase chain reaction (RT-PCR) and real-time PCR
Total RNA was extracted using the Trizol procedure: 1 lg RNA was reverse transcribed using M-MLV reverse transcriptase and the equivalent of 0.1 lg was used for the PCR reactions. Real-time PCR was performed in a MyIQ Biorad single color real-time PCR detection system using SYBR1 green dye. The data were evaluated from the MyIQ reports using Microsoft Excel. Melting curves and gel analyses were used to verify single products of the appropriate base-pair size. RT-PCR was performed with the primers listed in Table 1 .
Animals and experimental procedures
Hindlimb unloading model
Male wild-type BALB/c mice, 6-7 weeks old (Harlan Laboratories), were kept under controlled conditions at 248C on a 12:12 light/dark cycle. Twelve mice were divided into two groups (6 mice per group), control or loaded (CON) and hindlimb unloading (HLU). All experiments were conducted according to the institutional guidelines for animal welfare. The mice were subjected to HLU by tail suspension as described previously with some 
modifications [29] . Briefly, a steel wire was attached to the entire length of the dorsal surface of the tail with the help of cyanoacrylate glue. A hypoallergenic tape was loosely wound around the wire attached to the tail. The other end of the wire was connected to a swivel that would allow 3608 rotation of the mouse when standing at one point. The swivel was attached to a fishing leader that could slide over a horizontal bar at the top of the cage, enabling further movement from one end of the cage to another. The height of the bar was adjusted to maintain the body in a 308 tilt with the hindlimbs elevated above the floor of the cage. Mice could easily move around on the cage surface, although they could not lean on walls with their hindlimbs. All mice were acclimatized for 1 week before HLU and had free access to food pellets. Water was provided in Petri dishes and changed twice a day. The mice in the unloading group (HLU) were subjected to unloading for 4 weeks. Loaded control mice (CON) were also housed individually under the same conditions except for tail suspension. After 4 weeks of tail suspension, dual-energy X-ray absorptiometry (DEXA) analysis of femurs was performed, following which the mice were anesthetized with pentobarbital and then killed by cervical dislocation. The femora and tibiae were separated from adherent muscles and connective tissues. The femurs were used for histomorphometry and micro-CT (lCT) analysis, respectively, after filtration in a 10% neutral buffered formalin solution for 48 h, rinsed with distilled water, and stored in 70% ethanol.
Ex vivo cell analysis
The tibiae were used to flush out bone marrow cells for ex vivo cell analysis. Mouse bone macrophages were generated from the bone marrow cells and then allowed to differentiate after stimulation with RANKL (20 ng/ml) and M-CSF as described in Materials and methods. After 4 days of stimulation, half the cells were used for RNA extraction and cDNA preparation. RT-PCR was performed with the cDNA to determine the levels of osteoclastogenesis markers TRAP, cathepsin K, calcitonin receptor, and 18S. After 5 days of stimulation, the other half of the cells were TRAP stained and the total number of osteoclasts ([3 nuclei) was counted per field using a light microscope.
Measurement of bone mineral density
Bone mineral density (BMD) of the entire femora was measured by DEXA using a Lunar PIXImus densitometer (GE Lunar Corp., Madison, WI, USA) and expressed as an observed mean (g/cm 2 ) ± the standard deviation within the whole group.
Micro-CT
After the animals were killed, femurs were removed and dissected free of soft tissue. The bones were then fixed in 10% v/v formaldehyde and analyzed by lCT using the manufacturer's included 3D analysis software (lCT 40; Scanco Medical, Bassersdorf, Switzerland). The region of interest analyzed was the metaphysis of the proximal femur, for a total of 12 specimens scanned. The trabecular bone just distal to the growth plate in femurs was scanned using a 6-lm slice increment to obtain 209 slices, of which 100 slices were selected in the typical area. For cortical bone, scanning was performed starting at 6.5 mm from the distal end of the femur to obtain 25 slices.
Quantitative histomorphometry
The left femurs of mice were bisected transversely at the midpoint of the shaft. Femurs were fixed in 10% v/v buffered formalin, decalcified in ethylenediaminetetraacetic acid (EDTA), embedded in paraffin, sectioned, and stained for TRAP. Furthermore, tissues were fixed, embedded in methyl methacrylate, sectioned, and stained with von Kossa stain. Quantitative histomorphometric analysis was performed using the area at least 0.5 mm below the growth plate, excluding the primary spongiosa and trabecular connected cortical region, and represented according to the rules described by Parfitt et al. [38] .
Statistics
Data are expressed as the mean standard error (SE) of at least three independent experiments each performed in triplicate wells. Statistical analysis was performed by the paired Student's t test in Microsoft Excel. A P value less than 0.05 was considered statistically significant.
Results
Modeled microgravity studies
Modeled microgravity system does not alter medium properties Medium properties were measured after 24 h MMG or G exposure of RAW264.7 cells and mouse bone marrow macrophages. The pH, pO 2 , and pCO 2 of the medium were collected anaerobically and assayed at 378C by a Radiometer ABL blood analyzer 700 Series. The pO 2 in mmHg (G = 176 ± 4.0, MMG = 178.5 ± 14.5), pCO 2 in mmHg (G = 44.3 ± 2.3, MMG = 49.05 ± 1.6), and pH (G = 7.46 ± 0.05, MMG = 7.42 ± 0.01) of the medium used for culturing RAW264.7 cells were unaltered in the MMG apparatus. To investigate whether the MMG system alters cell viability, apoptosis was assayed. Exposure in the RCCS for 24 h does not stimulate apoptosis in RAW264.7 cells (Fig. 1b) or mouse bone marrow macrophages (data not shown). Cells incubated for more than 24 h dissociated from the beads; therefore, incubations in MMG for longer than 24 h were not possible.
MMG exposure partially activates osteoclastogenesis pathways in osteoclast precursors without RANKL treatment MMG exposure for 24 h (with no RANKL treatment) did not lead to stimulation of osteoclastogenesis marker genes. The mRNA levels of the osteoclastogenesis marker genes, TRAP and cathepsin K, remained undetectable after 24-h exposure to MMG, similar to that observed in G (data not shown). Interestingly, there was increased phosphorylation of ERK, p-38, and PLCc2 after MMG exposure in RAW264.7 cells as compared to G-exposed cells. JNK phosphorylation remained unaffected (Fig. 2) . In addition, we also observed that MMG exposure led to an increase in the mRNA (Fig. 3a) , protein expression (Fig. 3c) , and nuclear translocation of NFATc1 (Fig. 3e) after MMG. Levels of c-fos, however, remain unaltered (Fig. 3a, c) . There was no significant difference in RANK (RANKL receptor) expression as determined by mRNA (Fig. 3b ) and protein expression (Fig. 3d ) after 24 h in MMG as compared to that in G.
Osteoclastogenesis after MMG exposure
After 24-h MMG exposure of RAW264.7 cells and mouse bone marrow macrophage precursors, the cells were cultured with RANKL in G for 3 days (RAW264.7 cells) or 4 days (mouse bone marrow macrophages). This treatment resulted in an increase in the mRNA expression of the osteoclastogenesis marker genes TRAP and cathepsin K (Fig. 4) . After RANKL stimulation, MMG-exposed osteoclast precursors formed a significantly higher number of multinucleated osteoclasts, especially those with [30 nuclei, as compared to the G-exposed cells (Fig. 5) .
Hindlimb unloading studies: validation of the model
Mean body weight
No significant change was observed in the body weight of mice during the course of HLU. The mean weight of the loaded control group (23.3 ± 3.9) was not found to be statistically different from the HLU group (21.1 ± 1.1 g) at the end of 28 days of study.
Hindlimb unloading leads to loss in BMD
To analyze how 28 days of HLU affects the bone of BALB/c mice, we first compared the BMD of femurs of loaded control and HLU mice by DXA analysis. As expected, HLU led to a significant reduction in the BMD of the femurs as compared to that of the loaded control mice (Fig. 6a) .
Hindlimb unloading leads to loss of three-dimensional (3D) microstructure of femurs
Most reports suggest that HLU mainly affects the trabecular bone in growing rats and mice [29, 37] . The effect of 28 days of HLU on the 3D microstructure of bone was studied using lCT, which showed HLU leads to a significant loss in the 3D microstructure of both the trabecular (Fig. 6b, c) and cortical bone (Fig. 6d,e) . The effect was quantitated in terms of the bone volume per fraction of the total volume at the trabecular and cortical regions (Fig. 6f, g ).
Histomorphometry
Histomorphometry was used to determine whether the decrease in bone was caused by an decrease in bone formation, or an increase in bone resorption, or both. Histomorphometric analysis of femurs of loaded control and HLU mice revealed that there was a significant increase in the number of osteoclasts (N.Ob/BS), loss of number of trabeculae (Tb.No), decrease in trabecular thickness (Tb.Th), and an increase in trabecular space (Tb.Sp). Bone formation parameter (BFR), mineralized apposition rate (MAR), and the number of osteoblasts (N.Ob/BS) remained unchanged ( Table 2) .
Ex vivo cell analysis
Bone marrow cells were flushed from the tibiae of loaded control and HLU mice after 28 days (three mice per group). Mouse bone marrow macrophages were prepared as described earlier [30] and then stimulated with 10 ng/ ml RANKL and M-CSF for 5 days. Multinucleated osteoclasts formed were TRAP stained and counted. Similar to the in vitro results (see Fig. 5b ), there was an Fig. 3 Modeled microgravity activates NFATc1 and has no effect on c-fos and receptor activator of NFkB (RANK) expression. RAW264.7 cells were exposed to MMG and G for 24 h. RNA was isolated and cDNA was prepared, followed by reverse transcriptase-polymerase chain reaction (RT-PCR) for NFATc1, c-fos, RANK, and 18S. a RT-PCR for NFATc1, c-fos, and 18S. b RT-PCR for RANK and 18S.
Whole cell lysate was prepared from MMG-and G-exposed cells for Western blot analysis. c Western blot for NFATc1, c-fos, and actin. d Western blot for RANK and actin. Nuclear and cytoplasmic lysates were prepared from MMG-and G-exposed cells. e Western blot for NFATc1 and actin for cytoplasmic and nuclear lysates. Each figure is representative of three independent experiments Fig. 4 Modeled microgravitymediated tartrate-resistant acid phosphatase (TRAP) and cathepsin K expression after RANKL treatment. RAW264.7 cells (a) and mouse bone marrow macrophages (b) were exposed to MMG and G for 24 h. Cells were separated from the beads and incubated with 10 ng/ml RANKL in G for 1 day. RNA was isolated and cDNA prepared, followed by quantitative real-time PCR for TRAP, cathepsin K, and 18S. Left panels levels of TRAP relative to 18S; right panels level of cathepsin K relative to 18S, in RAW264.7 cells. Relative gene expression (mean ± SEM) was obtained by normalizing to 18S expression and plotting on a log scale. *P B 0.05; **P B 0.001 J Bone Miner Metab (2011) 29:111-122 117 increase in the number of TRAP-positive multinucleated osteoclasts (Fig. 7a) . However, in this case, the effect was on the total number of multinucleated osteoclasts, in contrast to the in vitro observations where the effect was prominently on larger multinucleated osteoclasts ([30 nuclei).
Osteoclastogenesis markers were determined by RT-PCR and after 4 days of ex vivo culture of mouse bone marrow macrophages with RANKL and M-CSF. There was an increase in the expression of cathepsin K and calcitonin receptor. However, in contrast to our observations in vitro (see Fig. 4a, b) , there was no change in the level of TRAP Fig. 5 Modeled microgravity stimulates RANKL-mediated osteoclastogenesis. RAW264.7 cells (a) and mouse bone marrow macrophages (b) were exposed to MMG and G for 24 h. Cells were separated from the beads. RAW264.7 cells (a) were incubated with 10 ng/ml RANKL in gravity (G) for 5 days followed by TRAP staining. Mouse bone marrow macrophages (b) were incubated with 10 ng/ml RANKL and macrophage-colony stimulating factor (M-CSF) for 5 days. TRAP staining and counting of multinucleated osteoclasts were performed. TRAP-positive osteoclasts with 6-30 nuclei and with more than 30 nuclei were counted. Values were obtained from three independent experiments and represent mean ± SE. **P B 0.005; *P B 0.05; NS not significant Fig. 6 Dual-energy X-ray absorptiometry (DEXA) and micro-computed tomography (lCT) analysis. a Bone mineral density (BMD) measured by DXA in the femurs of loaded control (CON) or hindlimb unloaded (HLU) mice after 28 days. Data are mean ± SEM (n = 6). **P \ 0.001 versus age-matched loaded controls. Micro-CT analysis was performed on trabecular and cortical bones. b, c Representative three-dimensional (3D) images by lCT of trabecular bone at the proximal femur of loaded control (CON) and hindlimb unloaded (HLU) male mice. d, e Representative 3D images by lCT of cortical bone at the femur of loaded control (CON) and hindlimb unloaded (HLU) male mice. f Comparison of 3D trabecular bone volume fraction (BV/TV) between CON and HLU mice. n = 3; **P \ 0.001. g Comparison of 3D cortical bone volume fraction (BV/TV) between CON and HLU mice. n = 3; *P \ 0.05 mRNA expression (Fig. 7b) . Interestingly, RANK was also increased.
Discussion
A number of spaceflight studies indicate that bone loss is caused by a decrease in osteoblasts and an increase in osteoclasts. Using ground-based cell culture systems; the decrease in osteoblasts has been characterized and studied in depth [39] [40] [41] [42] . These studies have shown that MMG, using the same general design as the studies reported here, inhibits osteoblastogenesis [40] . In contrast, very few studies have focused on the direct effect of MMG on osteoclasts. We have established a ground-based system to study the direct effect of MMG on osteoclastogenesis and to investigate the molecular mechanism(s) involved. Our results show that short-term (24-h) MMG exposure of osteoclast precursors enhances their sensitivity to subsequent treatment with RANKL, which stimulates them to form giant multinucleated osteoclasts and an increase in osteoclastogenesis markers TRAP and cathepsin K. The effect is mediated by a RANKL-independent partial activation of the osteoclastogenesis pathways NFATc1, ERK, p-38, and PLCc2. NFATc1 is regarded as the master regulator of osteoclastogenesis. Once activated, it translocates into the nucleus and acts as a transcription factor for several osteoclast-specific genes. It is activated after RANKL stimulation of osteoclast precursors and, when ectopically overexpressed, is sufficient to induce osteoclastogenesis [43] . However, despite NFATc1 activation by MMG, osteoclastogenesis was not enhanced without RANKL treatment, which result could be due to the following reasons. First, osteoclast precursors have been exposed to MMG for only 24 h, and not for the normal duration of osteoclastogenesis, which is 96 h. Thus, the changes that are being induced during the short span of 24 h of MMG conditions might revert back once the cells are plated in the absence of RANKL in normal gravity conditions. Second, the cause might be that c-fos remains unaltered in MMG and c-fos activation may be necessary to stimulate spontaneous osteoclastogenesis. Cooperative interaction between NFAT and AP-1 (composed of jun and fos) on specific DNA-binding sites is required for the transcription of certain osteoclast-specific genes. C-fos-/-osteoclast precursors, which overexpress NFATc1, do not form osteoclasts in the absence of RANKL [44] .
Interestingly, we did not observe any changes in RANK expression, which indicates there may be involvement of costimulatory pathways such as ITAM-motif-bearing adaptor molecules DAP12 and its receptor TREM2, which are expressed on osteoclast precursors and, similar to RANK, have also been shown to activate PLCc2 [45] . Differentiation of osteoclast precursors has recently been shown to be stimulated during 10 days of spaceflight; however, in contrast to our study, these experiments have been performed in the presence of M-CSF and RANKL [46] . Monici et al. [47, 48] have reported that there is a direct stimulation of human osteoclast-precursor-like cells, FLG29.1 in MMG. In contrast to these results, we did not observe any direct stimulation of osteoclastogenesis in MMG. Rather, MMG enhanced the sensitivity to subsequently added RANKL and MCF. The disparity in the results could be explained by the use of different in vitro systems, different cell types, different duration of exposure, and/or the absence of beads in their system. Activation of PLCc2 is known to lead to an increase in intracellular calcium levels by inducing the release of endoplasmic reticulum calcium stores. Thus, intracellular calcium signaling might be a generalized cellular response of cells to microgravity and might explain a number of the physiological changes observed in microgravity. Intracellular Ca 2? is known to bind to calmodulin, which undergoes a conformational change and induces the activation of several downstream effector proteins including a serine/ threonine phosphatase, calcineurin, and calmodulindependent protein kinase II (CaMKII). We have shown previously that CaMKII is involved in osteoclastogenesis [49] and that calmodulin is essential for osteoclast activity [50] . Calcineurin is involved in NFATc1 activation and its inhibitors, cyclosporin A and FK506, have been shown to inhibit osteoclastogenesis in RAW264.7 cells [43] and to stimulate osteoblastogenesis in mice [51] . The sensitization of osteoclast precursor cells to RANKL-mediated osteoclastogenesis as observed here, and the inhibition of osteoblastogenesis as previously shown by our laboratory in the MMG environment [40, 41] , could possibly be reversed by calcineurin inhibitors when used at appropriately low concentrations. The effect of calcineurin inhibitors on microgravity-induced bone loss should be tested in the established in vitro (RCCS) and in vivo (mouse HLU model) systems.
The mouse HLU system has been used by several groups to define the role of bone cells in microgravityinduced bone loss. The role of osteocytes as mechanosensors has been emphasized. Aguirre et al. [52] found that HLU initially leads to osteocyte apoptosis, followed by osteoclast recruitment leading to bone loss. Fourteen days of HLU of rats resulted in a decrease in BMD at the tibial metaphysis from enhancement of bone resorption, as determined by an early increase of urinary resorption marker deoxypyridinoline (in 7 days), and an increase in the number of osteoclasts, as determined by histomorphometry [53] .
It has been observed in several unloading studies that bone formation is decreased as determined by serum markers of bone formation [54, 55] . In one study, bone histomorphometric analysis revealed that unloading leads to a decrease in bone osteoblast surface and bone collagen density, indicating a decrease in bone formation parameters [56] . However, we did not observe any significant reduction in bone formation parameters by histomorphometry (see Table 2 ). This discrepancy in the results might be because, in contrast with other studies, which were performed with mature rodents, we used rapidly growing mice. Li et al. [57] have observed by histomorphometry that cancellous bone loss occurred rapidly before 10 weeks of unloading and stabilized at 50% less bone mass after 18 weeks in rats, indicating that bone resorption might be the primary cause of bone loss in the initial periods of unloading and that later there is also a decrease in bone formation parameters. Thus, it is possible that we might also have observed a decrease in bone formation parameters if the unloading duration was increased in mice.
Although a number of HLU studies have been performed, none of them have compared results with an in vitro MMG system. The effect of MMG on osteoclast precursors in our hands is verified in the in vivo hindlimb system. For this purpose, we isolated mouse bone marrow macrophages from the hindlimbs of unloaded mice and cultured them ex vivo and found that they formed more multinucleated TRAP-positive osteoclasts than those isolated from the loaded control mice. There was also an increase in the expression of osteoclastogenesis markers cathepsin K and calcitonin receptor, but no change in TRAP expression. Although there is a discrepancy in the effect of HLU and MMG on TRAP expression, this could be because TRAP is an early marker of osteoclastogenesis and, although it was measured early on (day 1) after RANKL treatment in MMG-exposed cells, TRAP levels were analyzed after 4 days of RANKL treatment in mouse bone macrophages cultured from HLU mice.
Therapies for preventing HLU-induced bone loss have mainly used bisphosphonates, which suppress resorption. Recently, Lloyd et al. [58] showed that the use of a lowdose bisphosphonate, zolendronic acid, in conjunction with osteoprotegerin prevents bone loss occurring in mice caused by 28 days of HLU. Bikle et al. [35] administered alendronate alone, which targets resorption, to suppress unloading-induced bone loss in rats. Very few anabolic studies have been designed that target bone formation pathways for preventing unloading-induced bone loss. However, in one such study by Turner et al. [59] , intermittent parathyroid hormone used at a human therapeutic dose prevented the skeletal changes associated with HLU in skeletally mature (6 months old) male rats; this finding was accompanied by an increase of serum markers of bone formation. Although in a gravity environment intermittent administration of parathyroid hormone (PTH) increases bone mass by increasing formation over resorption and continuous administration induces bone loss through large increases in resorption [60, 61] , Ono et al. [62] have observed that constitutively active PTH/parathyroid hormone-related protein (PTHrP) signaling in osteoblasts was able to suppress unloading-induced bone loss in mice. The mechanism appears to involve osteoblast-mediated regulation of osteoclastic resorption activity. This response of bone to the constitutively active PTH receptor suggests that a different mechanism of bone loss is involved in unloading. Furthermore, Baek et al. [63] showed that blocking badrenergic receptors and replacing leptin was able to prevent HLU-induced bone loss.
A recent study by Lin et al. [64] implicates the role of osteocytes in unloading-induced bone loss. Here, the authors presented evidence that secretion of sclerostin by osteocytes is increased in unloading. Sclerostin, an inhibitor of Wnt/b-catenin signaling, inhibits osteoblastogenesis. By using the in vitro system we have established that both osteoblast and osteoclast precursors show a direct response to reduced gravity. We propose that these direct effects of microgravity occur in addition to the activation of the osteocyte/sclerostin axis. Also, from our studies it would appear that use of our in vitro MMG systems can yield valuable insight into the mechanisms of cellular alterations occurring in microgravity conditions that in turn could lead to identifying novel drug targets. Our in vitro systems (validated by in vivo system) can also be used as a drug assessment test system in which drugs that would affect bone formation and resorption differentially can be tested.
